Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,858 total articles

SIVEF: Positioning for a Funded Production Ramp — Tactical Long

SIVEF: Positioning for a Funded Production Ramp — Tactical Long

Sivers Semiconductors' intraday strength, improving technical momentum and a shrinking short base suggest the market is starting to price in a production inflection. With no current market-cap citation on the listing used here and a prior trading range well above today's levels, a calibrated long with a tight stop and a clear target captures upside…

Sell-Off Aftershock Creates a Buying Window in Celestica (CLS)

Sell-Off Aftershock Creates a Buying Window in Celestica (CLS)

Celestica plunged after a recent headline despite beating Q1 estimates and raising full-year guidance. Fundamentals show rapid revenue growth, strong ROE and positive free cash flow; short interest and heavy intraday short volume increase the odds of a mean-reversion trade. This is a tactical long idea with a clear entry, stop and target for a mid-…

Energy Transfer: Growth Capex + Distribution Safety Create a Tactical Buy

Energy Transfer: Growth Capex + Distribution Safety Create a Tactical Buy

Energy Transfer (ET) is trading near $20.60 with a 6.6%-6.8% yield, elevated but sustainable distributable cash flow, and a multi-billion-dollar growth backlog tied to natural gas capacity for data centers and gas-to-power projects. The business combines toll-like cash flow with visible growth catalysts; this trade idea buys the combination of yiel…

Devon Energy: The Market Still Undervalues the Combined Operator

Devon Energy: The Market Still Undervalues the Combined Operator

Devon has finished integrating Coterra and laid out an aggressive capital-return plan, but the stock is trading below key technicals and well inside a valuation band that doesn't fully reflect $2.4B of free cash flow, $600M in targeted synergies and explicit debt retirement. We think a disciplined long with a clear stop and a realistic target captu…

Victoria's Secret Has Reclaimed Its Identity - Buy the Re-rate

Victoria's Secret Has Reclaimed Its Identity - Buy the Re-rate

Victoria's Secret has stopped trying to be everything to everyone and is once again selling aspirational lingerie and intimate apparel at healthier margins. The stock has room to re-rate as comps stabilize, promotional pressure eases and management monetizes new distribution channels. Enter a tactical long with a clear stop and a medium-term target…

ANI Pharmaceuticals: Buy the Next Chapter, Not the Last Quarter

ANI Pharmaceuticals: Buy the Next Chapter, Not the Last Quarter

ANI Pharmaceuticals (ANIP) looks like a buy for patient traders. The market is focused on recent execution - which has been solid - but may be underpricing the commercial and rare-disease optionality from ILUVIEN and continued rare-disease tailwinds. With a market cap near $1.82B, FCF of $179M and management guiding to north of $1B in revenue for 2…

MNTN: Cash Flow Breakthrough Makes a Playable Re-rate

MNTN: Cash Flow Breakthrough Makes a Playable Re-rate

MNTN looks set to trade higher as operating cash flow catches up with earnings and the company's net-cash balance sheet separates enterprise value from headline market cap. Premium multiples still price growth, but a clear path to stronger free cash generation and several near-term catalysts create a pragmatic trade: enter at $10.30, target $14.00,…